Alpha Tau Medical Analyst Ratings
Alpha Tau Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 150% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 150% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 233.33% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 455.56% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 427.78% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 483.33% | Citigroup | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/18/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 购买 → 购买 |
| 05/24/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 购买 → 购买 |
| 05/18/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 购买 → 购买 |
| 05/15/2023 | 150% | HC Wainwright & Co. | → 9 美元 | 重申 | 购买 → 购买 |
| 2023 年 4 月 24 日 | 150% | HC Wainwright & Co. | → 9 美元 | 启动覆盖开启 | → 购买 |
| 2022 年 11 月 23 日 | 233.33% | 派珀·桑德勒 | 19 美元 → 12 美元 | 维护 | 超重 |
| 2022 年 4 月 14 日 | 455.56% | 坎托·菲茨杰拉德 | → 20 美元 | 启动覆盖开启 | → 超重 |
| 04/08/2022 | 427.78% | 派珀·桑德勒 | → 19 美元 | 启动覆盖开启 | → 超重 |
| 2022 年 4 月 4 日 | 483.33% | 花旗集团 | → 21 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的目标价格是多少？
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by HC Wainwright & Co. on August 18, 2023. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 150.00% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月18日公布了Alpha Tau Medical（纳斯达克股票代码：DRTS）的最新目标股价。该分析公司将目标股价定为9.00美元，预计DRTS将在12个月内上涨至150.00％（可能上涨150.00％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的最新分析师评级是多少？
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.
HC Wainwright & Co. 提供了Alpha Tau Medical（纳斯达克股票代码：DRTS）的最新分析师评级，Alpha Tau Medical重申了买入评级。
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Alpha Tau Medical的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Alpha Tau Medical的最后一次评级是在2023年8月18日提交的，因此你应该预计下一个评级将在2024年8月18日左右公布。
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
分析师对Alpha Tau Medical（DRTS）的评级是否正确？
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $0.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $3.60, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Alpha Tau Medical（DRTS）评级，目标股价为0.00美元至9.00美元。Alpha Tau Medical（DRTS）目前的交易价格为3.60美元，在分析师的预测区间内。